Antibodies against cyclic citrullinated peptide in Japanese psoriatic arthritis patients
- 25 March 2010
- journal article
- case report
- Published by Wiley in The Journal of Dermatology
- Vol. 37 (4), 339-345
- https://doi.org/10.1111/j.1346-8138.2010.00814.x
Abstract
Anti-cyclic citrullinated peptide antibodies (anti-CCP) are highly considered to indicate disease severity and be predictive markers in rheumatoid arthritis (RA). RA patients who are positive for anti-CCP tend to progress more frequently to joint deformity and functionally deteriorate more than negative patients. A study concerning the presence of anti-CCP in Japanese patients with psoriatic arthritis (PsA) has been published. Our aim was to clarify that anti-CCP could be a potentially useful marker in PsA patients. We herein describe a PsA patient with presence of anti-CCP. We examined anti-CCP in 15 patients with PsA, and compared with 18 controls who had other types of psoriasis. Three PsA patients were positive for anti-CCP, but no controls showed positive. The anti-CCP-positive patients had higher counts of radiographic erosion, higher prevalence rates of polyarticular disease, use of disease-modifying anti-rheumatic drugs, and the human leukocyte antigen DRB1*04 shared epitope than negative patients. Our study demonstrated that anti-CCP was potentially both predictive and a severity marker of joint involvement in PsA, the same as in RA.Keywords
This publication has 22 references indexed in Scilit:
- Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritisClinical Rheumatology, 2006
- Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammationAnnals Of The Rheumatic Diseases, 2006
- Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritisAnnals Of The Rheumatic Diseases, 2005
- The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritisRheumatology, 2005
- The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritisArthritis & Rheumatism, 2000
- Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onsetArthritis Research & Therapy, 2000
- The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptideArthritis & Rheumatism, 2000
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.JCI Insight, 1998
- The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.JCI Insight, 1995
- New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear FactorAnnals Of The Rheumatic Diseases, 1964